BB Biotech AG (BBZA.DE)
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG.
56.60+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+69.5%
The outlook
BB Biotech AG currently reads as bullish based on strong buy — 1.0 avg of 1 analysts, above its 50- & 200-day averages, 99% of the way from its 52-week low to high, avg target +10% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendAbove its 50- & 200-day averages
52-week range99% of the way from its 52-week low to high
Price targetAvg target +10% vs current price
Market cap
$3.12B
52-wk high
56.90
52-wk low
33.40
50-day avg
33.40
200-day avg
33.40
Trailing P/E
—